✦ LIBER ✦

The problem of nonresponding estrogen receptor-positive patients with advanced breast cancer

✍ Scribed by Heinrich Maass; Walter Jonat; Gunther Stolzenbach; Professor Gunther Trams

Publisher: John Wiley and Sons
Year: 1980
Tongue: English
Weight: 258 KB
Volume: 46
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19801215)46:12+<2835::aid-cncr2820461420>3.0.co;2-m

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of a displacement assay with

Evaluation of a displacement assay with tamoxifen as prognostic indicator in breast-cancer patients with estrogen-receptor-positive tumors

✍ Emanuel Levin; Andrea M. Actis; Silvana Caruso; Hugo Gass; Raquel Romero; Nicolá 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 95 KB 👁 2 views

A displacement assay with tamoxifen, based on the relative binding affinity of tamoxifen and estradiol for the estrogen receptor (ER), was proposed in 1990 as prognostic indicator for breast-cancer patients. Validation of its predictive results in relation to the outcome of 73 patients with ER ؉ tum

The prognostic value of estrogen recepto

The prognostic value of estrogen receptor determinations in patients with primary breast cancer: An update

✍ Philip Furmanski; Dwight E. Saunders; Samuel C. Brooks; Marvin A. Rich 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB 👁 2 views

The value of estrogen and progesterone r

The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates with response to tamoxifen

✍ Werner Robert Bezwoda; Jan D. Esser; Roger Dansey; Ivan Kessel; Myron Lange 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB 👁 2 views

Selection of hormone-responsive advanced

Selection of hormone-responsive advanced breast cancer with a cytoplasmic estrogen receptor assay. Analysis of 100 cases

✍ Peizhen Chen; Zhijia Mei; Xianyun Yao; Xiangin Meng 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 1 views

Treatment of metastatic breast cancer in

Treatment of metastatic breast cancer in estrogen receptor positive patients a randomized trial comparing tamoxifen alone versus tamoxifen plus CMF

✍ W. R. Bezwoda; D. Derman; N. G. De Moor; M. Lange; J. Levin 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB 👁 2 views

Association of increased lytic effector

Association of increased lytic effector cell function with high estrogen receptor levels in tumor-bearing patients with breast cancer

✍ C. C. Zielinski; E. Tichatschek; C. Müller; W. Kalinowski; P. Sevelda; K. Czerwe 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB 👁 2 views